PreveCeutical Medical Inc.

PreveCeutical Medical Inc. is a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature identical products.

Recent News

  • PreveCeutical Announces Appointment of Dr. Makarand Jawadekar as President

    Vancouver, British Columbia--(Newsfile Corp. - February 13, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to announce the appointment of Dr. Makarand (Mak) Jawadekar as the President of the Company, effective immediately. Dr. Jawadekar will also continue as the Chief ...

    2019-02-13 8:30 AM ET
  • PreveCeutical Announces Closing of Non-Brokered Private Placement

    Vancouver, British Columbia--(Newsfile Corp. - February 12, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces the closing of a non-brokered private placement financing (the "Financing"). A total of 6,100,000 units (the "Units") were issued under the Financing at a price of $0.05 ...

    2019-02-12 8:30 AM ET
  • PreveCeutical to Explore Partnerships with Pharmaceutical and Biotechnology Companies for the Co-Development of its Sol-Gel System

    Vancouver, British Columbia--(Newsfile Corp. - January 29, 2019) - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), announces that it plans to commence exploratory discussions with pharmaceutical and biotechnology companies developing therapies for neurological disorders, that are seeking a targeted nose-to-brain drug delivery system ...

    2019-01-29 8:00 AM ET
  • PreveCeutical Provides Update on the Dual Gene Therapy Program

    Vancouver, British Columbia--(Newsfile Corp. - January 14, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to provide an update on its dual gene therapy program, an important and fundamental aspect of which involves the design, synthesis and screen

    2019-01-14 8:30 AM ET
  • PreveCeutical Provides Update on Research Program for Development of Non-Addictive Analgesics

    Vancouver, British Columbia--(Newsfile Corp. - January 8, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to announce that it has recently completed a systematic and comprehensive series of in silico guided design, synthesis and potency screening of a library of carefully ...

    2019-01-08 8:30 AM ET